{"entity":{"id":"chengdu-zenitar-biomedical-technology","kind":"company","name":"Chengdu Zenitar Biomedical Technology","aka":["Chengdu Zenitar Biomedical Technology Co., Ltd"],"tldr":"Chengdu Zenitar Biomedical Technology is a Chinese developer in Chengdu that sponsors 6 registered cancer trials of Purinostat and Purinostat Mesylate.","summary":"Chengdu Zenitar Biomedical Technology appears on ClinicalTrials.gov as the industry sponsor of 6 interventional cancer trials (phase 1/2, 2, 3), testing Purinostat, Purinostat Mesylate, Selinexor, Flonoltinib in advanced solid tumor, recurrent and refractory diffuse large b-cell lymphoma, diffuse large b cell lymphoma，dlbcl, polycythemia vera (pv). OnCo records the company from the registry alone: the head office city comes from its registered name, and there are no website, funding or approval claims until they are sourced.","asOf":"2026-09-11","links":[{"label":"ClinicalTrials.gov: trials sponsored by Chengdu Zenitar Biomedical Technology","url":"https://clinicaltrials.gov/search?spons=Chengdu%20Zenitar%20Biomedical%20Technology"}],"tags":["ctgov-sponsor","china","registry-only"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["nct06431243","nct07011056","nct05563844","nct07232290","nct06485219","nct06484829"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"hq":"Chengdu, China","country":"CN","companyType":"biotech","investors":[],"funding":[]},"route":"/companies/chengdu-zenitar-biomedical-technology/","neighbours":{"trial":[{"id":"nct06431243","kind":"trial","name":"A Clinical Study of Purinostat Mesylate for Injection in Patients With Advanced Solid Tumors","route":"/trials/nct06431243/"},{"id":"nct06485219","kind":"trial","name":"A Phase IIa Clinical Study of Purinostat Mesylate for Injection in Patients With Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma","route":"/trials/nct06485219/"},{"id":"nct07011056","kind":"trial","name":"A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma","route":"/trials/nct07011056/"},{"id":"nct07232290","kind":"trial","name":"Phase IIa Study of Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia Vera","route":"/trials/nct07232290/"},{"id":"nct06484829","kind":"trial","name":"Purinostat Mesylate Combined With Pomalidomide Capsules and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma","route":"/trials/nct06484829/"},{"id":"nct05563844","kind":"trial","name":"Study of Purinostat Mesylate for Injection in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)","route":"/trials/nct05563844/"}]}}